NCCN updated its SCLC guidelines to recommend testing in patients with suspected PNS; however, researchers found uptake in the US is low.

ALTON If you (or someone you know) is a smoker or a previous smoker, completing a low-dose CT screening could save your ...

Lung cancer remains the leading cause of cancer death in the U.S., responsible for about 1 in 4, but major advances in ...

November is Lung Cancer Awareness Month, a time to raise awareness and educate the public about the leading cause of cancer ...

Pfizer Inc. ( PFE) Discusses Clinical Development Strategy for 4404 Bispecific Antibody in Oncology November 10, 2025 8:30 AM EST ...

According to experts, a baby born today has a 40 per cent chance of living for 150 years, largely due to advances in medical technology ...

Iams, MD, MSCI, discussed potential ways to determine which patients benefit most from additional therapy for extensive-stage ...

Sales of the drug, which comprised nearly half of Merck’s sales last year, totaling $29.5 billion, are expected to peak around $32.7 billion next year, and then begin a slow slide as it loses ground ...

Lung cancer remains a major public health challenge here—it is the most common cancer and the leading cause of cancer-related death, particularly among ... development to evaluate its activity in ...

The ARV-806 data presented show a differentiated profile based on degradation potency, antiproliferative activity, and induction of cancer cell death. ARV-806 is designed ... colorectal and non-small ...